Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2022-04-06 00:00:00 ET · period of report 2022-04-04 · accession 0001162194-22-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-06 | 2022-04-04 | LAB | Witney Frank | Dir | A - Grant | $0.00 | +15.9K | 15.9K | New | $0 |
| D | 2022-04-06 | 2022-04-04 | LAB | Witney Frank | Dir | A - Grant | $0.00 | +23.4K | 23.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-04 | A | A | 15,852 | $0.00 | 15,852 | D | — | — | (F1) Represents Restricted Stock Units that vest in four equal annual installments beginning April 4, 2023. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-04-04 | A | A | 23,401 | $0.00 | 23,401 | D | $3.99 · — to 2032-04-04 | 23,401 Common Stock | (F3) The Option becomes exercisable in four equal annual installments beginning on April 4, 2023. |